This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Alexander Kleinsmann, PhD
Director R&D, CMC Development at Bachem AG
Speaker

Profile

Alexander Kleinsmann is an organic chemist by training and focuses on technology and process development for peptide manufacturing at Bachem’s Swiss site. He earned his PhD in the group of Prof. Boris Nachtsheim at the University of Tübingen, working on cyclic dipeptides and peptide‑based supramolecular systems. Since joining Bachem in 2015, he has contributed to the development of scalable, robust, and sustainable platforms for peptide synthesis and purification used in late‑stage development and commercial production. As Director of R&D VI, he works with cross‑functional teams on process development and characterization for large‑scale peptide manufacturing, including the evaluation and implementation of advanced technologies such as MCSGP for downstream processing

Agenda Sessions

  • A Mild and Sustainable Platform for Disulfide Bond Formation in Peptide Manufacturing Using Dehydroascorbic Acid

    9:00am